Ocugen, Inc.

Equities

OCGN

US67577C1053

Market Closed - Nasdaq Other stock markets 01:30:00 13/03/2026 am IST			5-day change	1st Jan Change
2.340 ^USD	+1.74%		+34.48%	+73.33%

11/03	Top Midday Gainers	MT
11/03	Oppenheimer Initiates Ocugen at Outperform With $10 Price Target	MT

Transcript : Ocugen, Inc. - Special Call

Published on 01/15/2026 at 09:36 pm IST - Modified on 01/16/2026 at 12:35 am IST

S&P Capital IQ

Presentation Operator Message
Operator (Operator)

Good morning, and welcome to Ocugen's webcast to discuss data from the first half of patients completing 1 year since treatment in the OCU410 Phase II

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

Latest news about Ocugen, Inc.

11/03	Top Midday Gainers	MT
11/03	Oppenheimer Initiates Ocugen at Outperform With $10 Price Target	MT
09/03	312,319,623 Common Stock of Ocugen, Inc. are subject to a Lock-Up Agreement Ending on 9-MAR-2026.	CI
09/03	Certain Warrants of Ocugen, Inc. are subject to a Lock-Up Agreement Ending on 9-MAR-2026.	CI
09/03	Certain Performance Stock Units of Ocugen, Inc. are subject to a Lock-Up Agreement Ending on 9-MAR-2026.	CI
09/03	Certain Restricted Stock Units. of Ocugen, Inc. are subject to a Lock-Up Agreement Ending on 9-MAR-2026.	CI
04/03	Ocugen, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025	CI
04/03	Ocugen, Inc., Q4 2025 Earnings Call, Mar 04, 2026
04/03	Ocugen, Inc. Auditor Raises 'Going Concern' Doubt	CI
02/03	Ocugen Announces Phase 3 Limelight Enrollment Completion for Ocu400, A Novel Modifier Gene Therapy for Broad Retinitis Pigmentosa	CI
09/02	Ocugen, Inc. Announces Executive Changes, Effective February 9, 2026	CI
09/02	Ocugen Names Rita Johnson-Greene as CFO	MT
09/02	Ocugen appoints Rita Johnson-Greene to chief financial officer	RE
09/02	Ocugen, Inc. Appoints Rita Johnson-Greene as Chief Financial Officer	CI
23/01	Ocugen Closes $20.9 Million Registered Direct Offering	MT